BioNTech SE (BNTX)

BioNTech SE (BNTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $22.1B; returns 1 day -1.7%, 1 week +0.5%, 1 year -15.9%.

BioNTech SE is a German biotechnology company specializing in mRNA therapeutics, cancer immunotherapies, and vaccines. It operates as a tech-bio platform with in-house GMP manufacturing for mRNA and other biologics, supported by AI-driven discovery and development infrastructure.

Groups BNTX belongs to

• Biotechnology
• Biopharmaceutical
• Oncology
• Immunotherapy
• Life Sciences
• Healthcare
• Clinical Stage Biopharma
• Commercial Stage Biotech
• Biologics
• R&D
• Infectious Diseases
• COVID-19

BNTX financial model: income statement, cash flow and balance sheet